Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Scientists seek genetic clues to distinguish harmless from harmful tumors

NCT ID NCT01005654

Summary

This study aims to collect and analyze tissue samples from people who are already scheduled for surgery to remove endocrine tumors (like thyroid, adrenal, or pancreatic tumors). Researchers will study the genetic and molecular details of these tumors to learn how to better tell the difference between benign (non-cancerous) and malignant (cancerous) growths. The goal is to gather knowledge that could improve future diagnosis and treatment, but this study itself does not provide any experimental treatment to participants.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEUROBLASTOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • National Institutes of Health Clinical Center

    RECRUITING

    Bethesda, Maryland, 20892, United States

Conditions

Explore the condition pages connected to this study.